Cosmetic

Renowned British Plastic Surgeon Mr. Norman Waterhouse Joining Bizrahmed, Dubai

Retrieved on: 
Tuesday, April 16, 2024
Rhinoplasty, International Society, Cosmetic, Surgeon, Patient, Health, Otorhinolaryngology, Dentistry

DUBAI, UAE, April 16, 2024 /PRNewswire/ -- Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse.

Key Points: 
  • DUBAI, UAE, April 16, 2024 /PRNewswire/ -- Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse.
  • Mr. Norman Waterhouse has been featured in the prestigious Tatler Beauty & Cosmetic Surgery Guide 2021, and this is a testament to his expertise in the field.
  • Recognised for his remarkable work in plastic surgery, this inclusion puts Mr. Waterhouse amongst the top cosmetic surgeons globally.
  • Mr. Waterhouse's past roles include being the President of both the British Association of Aesthetic Plastic Surgeons (BAAPS) and the International Society of Aesthetic Plastic Surgery (ISAPS).

Renowned British Plastic Surgeon Mr. Norman Waterhouse Joining Bizrahmed, Dubai

Retrieved on: 
Tuesday, April 16, 2024
Rhinoplasty, International Society, Cosmetic, Surgeon, Patient, Health, Otorhinolaryngology, Dentistry

DUBAI, UAE, April 16, 2024 /PRNewswire/ -- Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse.

Key Points: 
  • DUBAI, UAE, April 16, 2024 /PRNewswire/ -- Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse.
  • Mr. Norman Waterhouse has been featured in the prestigious Tatler Beauty & Cosmetic Surgery Guide 2021, and this is a testament to his expertise in the field.
  • Recognised for his remarkable work in plastic surgery, this inclusion puts Mr. Waterhouse amongst the top cosmetic surgeons globally.
  • Mr. Waterhouse's past roles include being the President of both the British Association of Aesthetic Plastic Surgeons (BAAPS) and the International Society of Aesthetic Plastic Surgery (ISAPS).

Diane Crecca and SG360° Team Up to Solve Beauty Marketers' Challenges

Retrieved on: 
Tuesday, April 9, 2024
Cosmetics, Marketing, Cosmetic, Emotion, History, Woman

WHEELING, Ill., April 9, 2024 /PRNewswire/ -- SG360° is pleased to announce it has retained Diane Crecca of Diane Crecca Consulting to represent the company in the beauty industry.

Key Points: 
  • WHEELING, Ill., April 9, 2024 /PRNewswire/ -- SG360° is pleased to announce it has retained Diane Crecca of Diane Crecca Consulting to represent the company in the beauty industry.
  • Diane is a stalwart marketer and relationship builder who loves the creative process with its many facets and emotions.
  • As a renowned fragrance evaluator, she has helped launch brands into the U.S. market with an emphasis on creative elements.
  • This arms beauty marketers with access to purchase history data across luxury items and known fragrance, cosmetics, and skincare users.

triLift By Lumenis Receives Medical Device License from Health Canada, Launches in Canada

Retrieved on: 
Monday, March 25, 2024
Facial muscles, Facial, DOI, Face, Eye, Patient, SAN, Gold, Aesthetics, RF, MDL, IPL, Health Canada, Eyelid, CO2, Intense, Skin, Invention, Vision, Laser, Region, Cosmetic, Physician, Muscle atrophy, Ageing, Medical imaging

SAN JOSE, Calif., March 25, 2024 /PRNewswire/ -- Lumenis Be, Ltd., a global leader in developing and commercializing energy-based solutions for the Aesthetic and Vision markets, is proud to announce that the Facial Muscle Stimulation treatment that has taken over the U.S. is now coming to Canada. triLift, the groundbreaking Dynamic Muscle Stimulation technology (DMSt™), has received a Medical Device License (MDL) from Health Canada.

Key Points: 
  • triLift, the groundbreaking Dynamic Muscle Stimulation technology (DMSt™), has received a Medical Device License (MDL) from Health Canada.
  • Finally, practitioners in Canada can go beyond the skin, to address a key cause of facial aging—the muscles.
  • triLift by Lumenis is a unique device, allowing providers to target a patient's specific need with a quick, comfortable treatment option.
  • "The clearance of triLift by Health Canada is a significant moment in the Canadian facial aesthetics market," said Lumenis Vice President & Regional President, Americas, Brad Oliver.

Global Vitamin B3-B4 Market Analysis Report 2023-2029 Featuring Lonza, Aurorium, Brother Enterprises, Jubilant Ingrevia, Eastman Chemical, Lasons, Glanbia, and Merck Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, February 26, 2024
Vitamins, Supplements, Health, Fitness & Nutrition, USD, Vitamin B4, Strategic planning, Ageing, Global health, B3, Prevalence, Animal feed, Vitamin, Dry, Notifiable disease, Cosmetic, Market, Research, Dietary supplement

The "Global Vitamin B3-B4 Market (2023 Edition): Analysis By Vitamin Type (Vitamin B3, Vitamin B4), Formulation (Dry, Liquid), By Application, By Region, By Country: Market Insights and Forecast (2018-2028)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vitamin B3-B4 Market (2023 Edition): Analysis By Vitamin Type (Vitamin B3, Vitamin B4), Formulation (Dry, Liquid), By Application, By Region, By Country: Market Insights and Forecast (2018-2028)" report has been added to ResearchAndMarkets.com's offering.
  • Emerging trends and growth opportunities in the global Vitamin B3-B4 market are thoroughly examined in the latest research.
  • The report delves into the intricacies of the market during the forecast period of 2024-2029, shining a light on critical market dynamics.
  • These insights offer key stakeholders, business leaders, and other interested parties a strategic edge in the evolving global Vitamin B3-B4 market.

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Retrieved on: 
Wednesday, February 21, 2024
Health, General Health, Transfer, Abdominoplasty, Skin, Patient, Adjuncts, Medicine, MD, Still Over It, MBA, Evidence-based medicine, AACS, Safety, Pitfalls, Elective surgery, Plasma, Cosmetic, American Academy

Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery’s 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 – 24.

Key Points: 
  • Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery’s 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 – 24.
  • “Apyx Medical is pleased to see Renuvion featured in a variety of insightful educational presentations during AACS 2024, which we believe will help to expand the awareness of our Helium Plasma Technology and its benefits,” said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical.
  • Demographic, procedure and safety data were collected and evaluated from a contiguous series of more than 450 patients, including 229 patients treated with Renuvion and 236 patients treated with Bipolar RF.
  • The researchers analyzed adverse events recorded by the body area during or post-procedure for each group.

Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER

Retrieved on: 
Thursday, February 29, 2024
Ethics, OTC, Marketing, Corporate action, Culture, Internal Revenue Service, Endo International, DOJ, United States bankruptcy court, Average revenue per user, Cosmetic, Pharmaceutical industry

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that its subsidiary, Endo Health Solutions Inc. ("EHSI"), has agreed to resolve all issues regarding previously disclosed U.S. Department of Justice ("DOJ") investigations of EHSI and other Company subsidiaries related to certain legacy marketing of Opana® ER. The Company voluntarily stopped marketing Opana® ER directly to U.S. healthcare providers in 2016 and stopped selling Opana® ER in 2017.

Key Points: 
  • DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that its subsidiary, Endo Health Solutions Inc. ("EHSI"), has agreed to resolve all issues regarding previously disclosed U.S. Department of Justice ("DOJ") investigations of EHSI and other Company subsidiaries related to certain legacy marketing of Opana® ER.
  • The Company voluntarily stopped marketing Opana® ER directly to U.S. healthcare providers in 2016 and stopped selling Opana® ER in 2017.
  • EHSI also agreed to resolve the DOJ's civil investigation of the sales and marketing of Opana® ER.
  • Endo submitted the DOJ resolutions to the Bankruptcy Court for approval, which Endo is seeking in conjunction with its proposed Plan of Reorganization.

Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER

Retrieved on: 
Thursday, February 29, 2024
Ethics, OTC, Marketing, Corporate action, Culture, Internal Revenue Service, Endo International, DOJ, United States bankruptcy court, Average revenue per user, Cosmetic, Pharmaceutical industry

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that its subsidiary, Endo Health Solutions Inc. ("EHSI"), has agreed to resolve all issues regarding previously disclosed U.S. Department of Justice ("DOJ") investigations of EHSI and other Company subsidiaries related to certain legacy marketing of Opana® ER. The Company voluntarily stopped marketing Opana® ER directly to U.S. healthcare providers in 2016 and stopped selling Opana® ER in 2017.

Key Points: 
  • DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that its subsidiary, Endo Health Solutions Inc. ("EHSI"), has agreed to resolve all issues regarding previously disclosed U.S. Department of Justice ("DOJ") investigations of EHSI and other Company subsidiaries related to certain legacy marketing of Opana® ER.
  • The Company voluntarily stopped marketing Opana® ER directly to U.S. healthcare providers in 2016 and stopped selling Opana® ER in 2017.
  • EHSI also agreed to resolve the DOJ's civil investigation of the sales and marketing of Opana® ER.
  • Endo submitted the DOJ resolutions to the Bankruptcy Court for approval, which Endo is seeking in conjunction with its proposed Plan of Reorganization.

Dr. Husam Almunajed Continues Partnership With Haute Beauty Network

Retrieved on: 
Friday, February 2, 2024
Partnership, Cosmetic, Life, Dental implant, Clinical, Teaching, Expert, Patient, Dental care, Georgetown University, Villanova University, Align Technology, Education, University, Dentist, Dentistry

NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Husam Almunajed is a highly skilled cosmetic and restorative dentist who has made a name for himself in creating beautiful and healthy smiles for his patients. With an undergraduate degree from Villanova University and a master's degree from Georgetown University, Dr. Almunajed continued his education at the University of Connecticut School of Dental Medicine, where he completed his dental degree and a 2-year residency focused on comprehensive dental care.

Key Points: 
  • Smile Expert from New York, Dr. Husam Almunajed, continues his partnership with Haute Beauty Network, now in his sixth year.
  • "With over 20 years of experience, Dr. Almunajed founded Empire Dental Aesthetics, a state-of-the-art practice located in Manhattan, New York, specializing in cosmetic and comprehensive dentistry."
  • With over 20 years of experience, Dr. Almunajed founded Empire Dental Aesthetics, a state-of-the-art practice located in Manhattan, New York, specializing in cosmetic and comprehensive dentistry.
  • As he continues to teach and mentor the next generation of dentists, Dr. Almunajed's legacy of excellence in dentistry will undoubtedly continue to grow.

Allē by Allergan Aesthetics is the Leading Aesthetics Loyalty Rewards Program in the U.S.

Retrieved on: 
Tuesday, January 23, 2024
Senior, Patient, ABBV, AB toxin, Business, VIP, Cosmetic, RL, Human, A-list, AbbVie

IRVINE, Calif., Jan. 23, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the results of a consumer survey designed to examine the value proposition of Allē, Allergan Aesthetics loyalty rewards program. The survey of Allē Members who have been treated in the past twelve months affirmed Allē's position as the leading aesthetics loyalty rewards program in the country, with a ninety-two percent satisfaction rate reported by survey respondents1*.

Key Points: 
  • IRVINE, Calif., Jan. 23, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the results of a consumer survey designed to examine the value proposition of Allē, Allergan Aesthetics loyalty rewards program.
  • From its inception, Allē has disrupted the aesthetics industry by offering the most robust rewards program in the category.
  • That's why Allē is the first and only aesthetics loyalty rewards program to give its users points on more than 40 brands, products, and treatments at their Allē provider—even those that are not Allē brands.
  • For providers looking to engage with Allē for Business, please contact your local Allergan Aesthetics Business Development Manager.